Humana Inc. (NYSE:HUM) Shares Sold by Captrust Financial Advisors

Captrust Financial Advisors lessened its holdings in Humana Inc. (NYSE:HUM) by 1.4% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 49,321 shares of the insurance provider’s stock after selling 676 shares during the quarter. Captrust Financial Advisors’ holdings in Humana were worth $15,622,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. Creative Financial Designs Inc. ADV raised its position in shares of Humana by 244.0% during the 3rd quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock worth $27,000 after acquiring an additional 61 shares in the last quarter. CarsonAllaria Wealth Management Ltd. raised its holdings in Humana by 111.4% during the second quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock worth $28,000 after purchasing an additional 39 shares in the last quarter. Atwood & Palmer Inc. purchased a new stake in shares of Humana during the 3rd quarter worth approximately $29,000. Ashton Thomas Securities LLC acquired a new position in shares of Humana in the 3rd quarter valued at $31,000. Finally, Your Advocates Ltd. LLP grew its position in shares of Humana by 81.8% in the 3rd quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock valued at $32,000 after buying an additional 45 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

HUM has been the subject of a number of research reports. Cantor Fitzgerald reissued a “neutral” rating and issued a $395.00 price target on shares of Humana in a research report on Tuesday, October 1st. KeyCorp began coverage on Humana in a report on Friday, October 11th. They issued a “sector weight” rating for the company. Royal Bank of Canada cut their price target on Humana from $400.00 to $265.00 and set an “outperform” rating on the stock in a research report on Tuesday, October 8th. Deutsche Bank Aktiengesellschaft reduced their price objective on Humana from $349.00 to $250.00 and set a “hold” rating for the company in a research note on Thursday, October 3rd. Finally, Oppenheimer lowered their target price on shares of Humana from $400.00 to $280.00 and set an “outperform” rating on the stock in a research report on Thursday, October 3rd. Twenty equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $315.86.

Humana Stock Down 0.1 %

Humana stock opened at $296.38 on Friday. The stock’s 50 day moving average price is $275.33 and its 200 day moving average price is $329.36. The company has a market cap of $35.69 billion, a PE ratio of 26.25, a price-to-earnings-growth ratio of 2.34 and a beta of 0.52. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $504.79.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, topping the consensus estimate of $3.48 by $0.68. The company had revenue of $29.30 billion for the quarter, compared to analyst estimates of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. On average, sell-side analysts predict that Humana Inc. will post 15.86 EPS for the current fiscal year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be issued a $0.885 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $3.54 dividend on an annualized basis and a yield of 1.19%. Humana’s dividend payout ratio (DPR) is presently 31.36%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.